The highly selective and oral phosphoinositide 3-kinase delta (PI3K-δ) inhibitor roginolisib induces apoptosis in mesothelioma cells and increases immune effector cell composition
Article in Translational Oncology (February 2024)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Article in Translational Oncology (February 2024)
Article in Cancer Drug Resistance (January 2024)
Article in International Journal of Toxicology (September 2023)